Placebo vs. Linoleic Acid Controlled Assessment of Treatment Efficacy in MS
Status:
Terminated
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
Several investigations have suggested that polyunsaturated fatty acids may promote
therapeutic effects in MS. This pilot study will determine whether omega-6 polyunsaturated
fatty acids (PUFAs),in the form of linoleic acid,can reduce disease activity and prevent
disability progression in patients with relapsing MS.This study will seek to measure disease
activity as seen on MRI scans in addition to measuring relapse rates.